Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health CatalystHCAT +0.66%49 3-Year EBITDA Growth Rate is 4.70% as of Mar. 2026, which is 45% below its 10-year median of 8.55. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $4.95 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 527 Healthcare Providers & Services companies, Health Catalyst ranks worse than 60.53% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 4.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 25.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Health Catalyst was 57.00% per year. The lowest was -15.00% per year. And the median was 8.55% per year.
Health Catalyst (NAS:HCAT) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Health Catalyst 3-Year EBITDA Growth Rate Related Terms
HCAT vs LFMD, AMWL, OPRX: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Health Catalyst's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Health Catalyst's 3-Year EBITDA Growth Rate falls into.
Health Catalyst 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 4.70% mean?
Health Catalyst (HCAT) has a 3-Year EBITDA Growth Rate of 4.70% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Health Catalyst and its competitors. This is 45% below median its historical median of 8.55. According to the industry distribution chart, Health Catalyst ranks #319 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 60.5%.
Is Health Catalyst's 3-Year EBITDA Growth Rate too high?
Health Catalyst's current 3-Year EBITDA Growth Rate of 4.70% is 45% below median its 10-year median of 8.55. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Health Catalyst's value of 4.70% is 53.9% below this industry median. Based on the distribution chart, Health Catalyst ranks #319 out of 527 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's 3-Year EBITDA Growth Rate compare to LFMD and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #319 out of 527 companies for 3-Year EBITDA Growth Rate. This places Health Catalyst in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Health Catalyst's value of 4.70% is 53.9% below this benchmark. While the company's 10-year median is 8.55 vs. the industry median of 10.20, Health Catalyst has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current 3-Year EBITDA Growth Rate of 4.70% is 53.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current 3-Year EBITDA Growth Rate is 4.70%, which is 45% below median its own 10-year median of 8.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $4.95, compared to a current price of $2.14 — trading 56.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 4.70%, which is 45% below median its 10-year median of 8.55 and 53.9% below the Healthcare Providers & Services industry median of 10.20. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Health Catalyst (HCAT), the current 3-Year EBITDA Growth Rate is 4.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $2.14 is trading 56.8% below its estimated GF Value™ of $4.95.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
3-Year EBITDA Growth Rate: 4.70% (45% below median its 10-year median of 8.55)
GF Value™: $4.95 vs. price of $2.14 (56.8% below fair value)
Industry Position: 53.9% below the Healthcare Providers & Services median (#319 of 527)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
